Jeffrey H. Samet, MD, MA, MPH
Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
General Internal Medicine

MD, Baylor College of Medicine
MPH, Boston University
MA, Brandeis University
BA, Brandeis University



My research has focused on alcohol and drug use, HIV infection and primary medical care with the following specific projects: linkage of alcohol and drug use treatment and primary medical care; addressing alcohol and drug use issues in the primary care setting; the impact of alcohol and drug use in HIV-infected persons; HIV prevention and treatment in Russian substance users; and establishing medical care for HIV-infected persons.

Diversity, Equity, Inclusion and Accessibility

I have worked at Boston City Hospital and Boston Medical Center for the vast majority of the past 4 decades in large measure as a consequence of my desire to serve a safety net community. My focus clinically and from a research perspective has been on patients seen in this setting in primary care, many of whom have substance use disorders and some with HIV infection. Minority populations are disproportionately impacted by these medical conditions.

It is valuable to leverage the power of diverse backgrounds, experiences, and perspectives in solving complex problems. To achieve this goal, support for individuals from underrepresented groups is needed and I have sought to do this in my extensive mentoring efforts. Highlights of this work has been my support as the primary mentor for two black faculty on their NIH career development awards (K awards). Other work advancing these training goal occurs in my support and work with the CRIT (Chief Resident Immersion Training) Program, RAMS (Research in Addiction Medicine Scholars) Program and the Inclusion Diversity & Equity In Addiction medicine, Addiction health professions, and Addiction research (IDEAAA) program.

As Section Chief of General Internal Medicine for nearly 20 years (2002 – 2021), we recruited and supported the largest number of faculty from underrepresented groups in the Department of Medicine.

Professor
Boston University School of Public Health
Community Health Sciences


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Faculty
Boston University Chobanian & Avedisian School of Medicine
Medicine
Clinical Addiction Research and Education Unit



Kaku So-Armah ZINC Diversity Supplement-Vanderbilt
04/30/2016 - 07/31/2016 (PI)
Vanderbilt University Medical Center


Kaku So-Armah ZINC Diversity Supplement: Vanderbilt
02/01/2015 - 04/29/2016 (PI)
Vanderbilt University Medical Center


Faculty Development Program Grant
09/30/1998 - 03/29/2002 (PI)
HHS/SAMHSA/Center for Substance Abuse Prevention
5 T26 SP08355 03


CTN New England Consortium Node (Central CTN Activities)
03/01/2025 - 02/28/2032 (Subcontract PI)
PI: Jeffrey H. Samet, MD, MA, MPH
Yale University School of Medicine NIH NIDA
2UG1DA015831-24

Advancing Clinical Research Training within Addiction Residency Programs
04/01/2024 - 02/28/2029 (PI)
National Institute on Drug Abuse/NIH/DHHS


Clinical Addiction Research and Education (CARE) Program Renewal
07/01/2022 - 05/31/2027 (Multi-PI)
PI: Jeffrey H. Samet, MD, MA, MPH
National Institute on Drug Abuse/NIH/DHHS
2R25DA013582-21

The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center
09/10/2021 - 08/31/2026 (PI)
National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS
5P01AA029541-04

MassHEAL - Reducing overdose deaths by 40% (2019-2023)
04/17/2019 - 03/31/2026 (PI)
National Institute on Drug Abuse/NIH/DHHS
3UM1DA049412-04S2

The National Drug Abuse Clinical Trials Network: New England Consortium Node (Central CTN Activities)
03/01/2022 - 02/28/2026 (Subcontract PI)
PI: Jeffrey H. Samet, MD, MA, MPH
Yale University School of Medicine NIH NIDA

Administrative Supplement to The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center
09/10/2021 - 08/31/2025 (PI)
National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

TRAC
09/10/2021 - 08/31/2025 (PI)
National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS
1P01AA029541-01

TALC
09/10/2021 - 08/31/2025 (PI)
National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting Treatment as Prevention
09/20/2022 - 06/30/2025 (Multi-PI)
PI: Jeffrey H. Samet, MD, MA, MPH
National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS
5R01AA030460-03

Showing 10 of 81 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2025 Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" 3R01AA030460-04S1
2025 Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" 5R01AA030460-04
2025 The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center 3P01AA029541-05S1
2025 Administrative Core 5P01AA029541-05-5222
2025 The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center 5P01AA029541-05
2025 Advancing Clinical Research Training within Addiction Residency Programs 5R25DA033211-12
2025 Clinical Addiction Research and Education (CARE) Program 5R25DA013582-24
2024 Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" 5R01AA030460-03
2024 Administrative Core 5P01AA029541-04-5222
2024 The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center 5P01AA029541-04
Showing 10 of 203 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. El-Bassel N, Samet JH, Cheng DM, Freisthler B, John Winhusen T, Walsh SL. Response to the Editor: Re: registration and multiple outcome testing in the HEALing Communities Study by Dennis M. Gorman and Ben G. Fitzpatrick. Int J Drug Policy. 2025 Nov; 145:105029. PMID: 41077014; DOI: 10.1016/j.drugpo.2025.105029;
     
  2. Katz R, Fisher T, Singer-Clark T, Soares Iii W, Carpenter J, Schuessler N, Stadler H, Sahovey A, McAlearney AS, Samet JH, Chatterjee A. Creation of a telehealth addiction consultation service at a rural hospital: a case study. Addict Sci Clin Pract. 2025 Sep 26; 20(1):76. PMID: 41013782; PMCID: PMC12465738; DOI: 10.1186/s13722-025-00596-5;
     
  3. Tsui JI, Bhatraju EP, Hallgren KA, Rhew IC, Samet JH. High-Dose Buprenorphine Treatment in the Setting of Fentanyl. JAMA Netw Open. 2025 Aug 01; 8(8):e2528119. PMID: 40839262; DOI: 10.1001/jamanetworkopen.2025.28119;
     
  4. Guyatt P, Babe G, Gayowsky A, Rosic T, Rodrigues M, Bach P, Perez R, de Oliveira C, Samet JH, Kerkerian G, Hann J, Dionne JC, Ahmed A, Kim D, Nolan S, Thabane L, Samaan Z, Dennis BB. Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort study. Drug Alcohol Depend Rep. 2025 Sep; 16:100368. PMID: 40837618; PMCID: PMC12361781; DOI: 10.1016/j.dadr.2025.100368;
     
  5. Brown JL, Larochelle MR, Fanucchi LC, Calvert DC, Campbell ANC, Chandler RK, Feaster DJ, Glasgow LM, Gibson EB, Holloway J, Lofwall MR, Mack A, Mack N, Nunes EV, Talbert JC, Tan S, Vandergrift N, Villani J, Asman K, Babakhanlou-Chase H, Bagley SM, Battaglia TA, Blevins D, Bridden C, Cheng DM, Christopher M, Cogan LW, Cunningham CO, Eggleston B, Fareed N, Fernandez S, Freedman DA, Freiermuth CE, Freisthler B, Gilbert L, Hammerslag L, Harris D, Hunt T, Hussain S, Huynh P, Jackson RD, Kauffman EB, Knott C, Knudsen HK, Lefebvre RC, Levin FR, Massatti R, McAlearney AS, Morgan JR, Lopez RM, Lounsbury DW, Newman L, Nickels K, Oga EA, Oller DA, Parran TV, Quinn M, Ramsey KS, Rapkin BD, Salsberry P, Stein M, Taylor JL, Teater J, Walters ST, Zarkin GA, El-Bassel N, Winhusen TJ, Samet JH, Walsh SL. Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial. Drug Alcohol Depend. 2025 Sep 01; 274:112785.View Related Profiles. PMID: 40684522; PMCID: PMC12302724; DOI: 10.1016/j.drugalcdep.2025.112785;
     
  6. Tilhou AS, Assoumou SA, Samet JH. Aligning Efforts to Boost Medications for Opioid Use Disorder and Pre-Exposure Prophylaxis for HIV. J Gen Intern Med. 2025 Jul 03.View Related Profiles. PMID: 40610667; DOI: 10.1007/s11606-025-09700-6;
     
  7. Magane KM, Dukes KA, Fielman S, Palfai TP, Regan D, Cheng DM, Lee H, Kraemer KL, Bullard MJ, Chen CA, Samet JH. Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 01; 185(6):635-645.View Related Profiles. PMID: 40257810; PMCID: PMC12013356; DOI: 10.1001/jamainternmed.2025.0522;
     
  8. Levin FR, Oyler DR, Babineau DC, Villani J, Chandler RK, Freeman PR, Alford DP, Fareed N, Mack N, Nguyen TQ, Walker DM, Adams J, Baker TJ, Beers D, Benjamin SN, Bhuiyan J, Blevins D, David JL, Dalvi N, D'Costa L, Feaster DJ, Glasgow L, Goddard-Eckrich DA, Han Y, Harris M, Hunt T, Knott C, Matson A, Mierzwa F, Newman L, Nunes EV, Oga EA, Roberts MF, Shadwick A, Shoben A, Slavova S, Stinson L, Zarkin GA, Freisthler B, Samet JH, Walsh SL, Winhusen TJ, Jackson RD, El-Bassel N. Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing? AJPM Focus. 2025 Dec; 4(6):100371. PMID: 41035949; PMCID: PMC12480870; DOI: 10.1016/j.focus.2025.100371;
     
  9. Chavez LJ, Yu O, Wartko PD, Braciszewski JM, Glass JE, Horigian VE, Arnsten JH, Murphy MT, Stotts AL, Bagley SM, Lapham GT, Samet JH. Opioid use disorder medications among youth in primary care: Subgroup analysis of the PROUD trial. Pediatr Open Sci. 2025; 1(2).View Related Profiles. PMID: 40718732; PMCID: PMC12288600; DOI: 10.1542/pedsos.2024-000392;
     
  10. Gilbert L, Chahine R, Chandler R, Feaster DJ, Kim E, Aldridge A, Bagley S, Balvanz P, Fernandez S, Rock P, Vickers-Smith RA, Villani J, Battaglia T, Brown J, Bush H, Chase RP, Collins T, D'Costa L, Damato-MacPherson C, David JL, Defiore-Hyrmer J, Freeman PR, Glasgow L, Hammerslag LR, Hotchkiss J, Hunt T, Hussain S, Kamanu V, Knott C, Knudsen HK, LaRochelle M, Laudate A, Lyons M, McMullan J, Nakayima J, Schackman BR, Slavova S, Tan S, Vandergrift N, Walters ST, Westgate PM, Wu E, Young AM, Zarkin GA, Freisthler B, Oga E, Samet JH, Walsh SL, Winhusen J, Jackson R, El-Bassel N. The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial. Int J Drug Policy. 2025 Jun; 140:104798.View Related Profiles. PMID: 40220509; PMCID: PMC12103987; DOI: 10.1016/j.drugpo.2025.104798;
     
Showing 10 of 494 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 494 publications over 40 distinct years, with a maximum of 30 publications in 2007 and 2021

YearPublications
19851
19872
19881
19891
19901
19911
19922
19934
19947
19952
19967
199710
19988
19995
20008
20019
20027
200319
200427
200511
200617
200730
200812
20099
201011
201113
201215
201315
201418
201514
201622
201720
201823
201919
202021
202130
202220
202317
202422
202513


Ambitious federal effort to curb overdoses shows no impact on deaths, initial study finds

WBUR 6/17/2024

Community-Based Interventions for Opioid Overdoses Fail to Reduce Deaths in Trial

Med Page Today 6/17/2024

Hospitals have specialists on call for lots of diseases — but not addiction. Why not?

NPR 9/30/2022

Hospitals have many disease specialists, but often not for addiction. Now, that's changing

WBUR 9/14/2022

Nicotine Patches, Nasal Sprays May Also Cut Alcohol Consumption: Study

Newsweek 8/10/2022

Studies conducted with aim to hinder smoking and drinking

Healthcare Purchasing News 8/9/2022

Varenicline and cytisine not more efficacious than nicotine to treat risky drinking and smoking, study says

News-Medical 8/8/2022

With ‘fentanyl everywhere’ and Black deaths soaring, advocates in Brockton test ways to save lives

WBUR 6/16/2022

Drug overdose deaths hit all-time high in the U.S.

WGBH 11/18/2021

A Massachusetts Study Aims to Reduce Opioid Overdose Deaths

HealthCity 7/7/2021

‘Gold standard’ underused for substance misuse

ACP Internist 11/1/2020

Opioid treatment trailer coming to Brockton thanks to Kraft donation

The Enterprise 10/7/2020

Program Improves Use of Chronic Opioid Therapy in HIV Care

Psychiatry Advisor 9/2/2020

Program Improves Use of Chronic Opioid Therapy in HIV Care

Drugs.com 8/27/2020

Fighting the Opioid Overdose Epidemic

Wicked Local 7/10/2020

Column: Offering Hope for Those Struggling with Opioids

The Salem News 6/18/2020

Study Will Help Combat Opioid Use In Bourne, Sandwich

The Bourne Enterprise 5/15/2020

'The world is going to hell': Coronavirus can be deadly for people recovering from addiction

USA Today 4/9/2020

An Historic Opioid Study

Public Health Post 10/25/2019

Stories are Powerful

Harvard Magazine 10/13/2019

A Moon Shot for the Opioid Crisis

Boston Globe 8/23/2019

As Scotland's 'Trainspotting' Generation Ages, the Dead Pile Up

New York Times 8/7/2019

Opioid-Related ER Visits Decline in Mass. – but Not Everywhere

Boston Globe 6/26/2019

ACP Issues Guidance for Physician Impairment

Healio 6/5/2019

ACP Guidance on Physician Impairment Emphasizes Rehabilitation

MedScape 6/3/2019

Reintegration of Previously Impaired Physicians Must Balance Patient Safety and Physicians’ Rights

MD Alert/Reuters Health 6/3/2019

Western Mass Participates in $89 Million Opioid Study

WGBY 5/28/2019

Greater New Bedford Community Health Center To Take Part In Opioid Research Study

SouthCoast Today 4/29/2019

Athol, Orange Included In $89M National Opioid Study

Athol Daily News 4/23/2019

Mass. Researchers Receive $89 Million To Combat Opioid Overdose Deaths

WBUR 4/19/2019

Boston Medical Center Receives $89m Federal Grant

The Boston Globe 4/18/2019

Boston Medical Center Receives $90M In Federal Funds To Fight Opioid Epidemic

Boston Business Journal 4/18/2019

Alcohol use disorder therapy could improve chronic liver disease outcomes

Healio 9/26/2018

Leaders call restricting methadone treatment to clinic settings outdated

Behavioral Healthcare Executive 7/5/2018

2019-2019 Society of General Internal Medicine (SGIM): Recognition Award of Exceptional Leadership, Contributions & Accomplishments as Division Chief
2018-2018 American College of Physicians (ACP): First Richard and Hinda Rosenthal Award from The Rosenthal Family Foundation
2017-2020 Best Doctors in America: Best Doctors, Information When it Matters Most
2017-2017 Society of General Internal Medicine (SGIM): Quality and Practice Innovation Award - Clinical Addiction Research and Education (CARE) Unit
2016-2016 Association for Medical Education and Research in Substance Abuse (AMERSA): John P. McGovern Award for Excellence in Medical Education
2016 Boston University School of Medicine: Endowed Professor - John Noble, MD, Professor in General Internal Medicine
2015-2015 Society of General Internal Medicine (SGIM): "Best Paper of the Year"
2013-2013 Boston University School of Medicine: Robert Dawson Evans Research Mentoring Award
2011-2011 National Institute on Drug Abuse (NIDA) International Program: Excellence in Mentoring Award
2010-2010 Massachusetts Medical Law Report: RX For Excellence Award - Leaders in Quality - Honoring Best Practices in Medicine
2010-2022 Boston Magazine: Best of Boston General Internal Medicine Physician
2003-2014 The Best Doctors in America: Best Doctors, Information When it Matters Most
2003-2003 The Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA): Excellence in Mentorship, Annual National Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

addiction medicine
alcohol
HIV
primary care

Available to Mentor as: (Review Mentor Role Definitions):
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

617.414.7444
Download vCard

Samet's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (698) concept(s)
_
Media Mentions
_
Co-Authors
See all (88) people
_
Similar People
See all (60) people
_
Same Department
Search Department